Press release
U.S. Pharmacogenomics Market Poised to Reach USD 5.6 Billion by 2031, Driven by Impressive 8.7% CAGR
U.S. Pharmacogenomics Market
The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Surge in number of key players who manufacture pharmacogenomic drugs and rise in adoption of key strategies such as partnership, agreement, acquisition, and business expansion by key players act as the key driving forces for growth of the U.S. pharmacogenomics market. For instance, in May 2020, Admera Health, a biotechnology research company announced partnership with Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare providers and patients to effectively manage genomic testing This important and strategic partnership allows Hygea to offer its customers high quality tests from Admera Health, such as PGxOne Plus for pharmacogenomics. Moreover, rise in application of pharmacogenomics in cardiovascular disease, infectious diseases, oncology, neurological diseases, and psychiatry drives the market growth.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐:
https://www.alliedmarketresearch.com/request-sample/47832
Key Benefits For Stakeholders
โข The study provides an in-depth analysis of the U.S. pharmacogenomics market and the current trends & future estimations to elucidate imminent investment pockets.
โข It presents a quantitative analysis of the market from 2022 to 2031 to enable stakeholders to capitalize on the prevailing market opportunities.
โข Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
โข Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the U.S. Pharmacogenomics market.
๐๐จ๐ฉ ๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐จ๐ ๐๐ง๐จ๐ฆ๐ข๐๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Thermo Fisher Scientific Inc.
โข Illumina, Inc.
โข F. Hoffmann-La Roche Ltd.
โข QIAGEN
โข Agilent Technologies, Inc.
โข Eurofins Scientific
โข Bio-Rad Laboratories, Inc.
โข Danaher Corporation
โข Becton, Dickinson and Company
โข Myriad Genetics, Inc.
๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐จ๐ ๐๐ง๐จ๐ฆ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: -
The pharmacogenomics market can be segmented based on technology, application, end-user, and region. Here's a brief overview:
By Technology
โข Next Generation Sequencing
โข Polymerase Chain Reaction
โข Gel Electrophoresis
โข Mass Spectrometry
โข Microarray
โข Others
By Application
โข Cardiovascular Diseases
โข Infectious Diseases
โข Oncology
โข Neurological Diseases
โข Psychiatry
โข Others
By End User
โข Hospitals & Clinics
โข Research Institutions
โข Academic Institutes
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/47832
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Pharmacogenomics Market Poised to Reach USD 5.6 Billion by 2031, Driven by Impressive 8.7% CAGR here
News-ID: 3065502 • Views: โฆ
More Releases from Allied Market Research (AMR)
Prepreg Market Analysis: Navigating Growth Trends and Forecast from 2026 to 2031
According to a recent report published by Allied Market Research, titled "Prepreg Market by Fiber Type, Resin Type, Manufacturing Process, End User Industry: Global Opportunity Analysis and Industry Forecast, 2021-2031," the global prepreg market was valued at $6.3 billion in 2021 and is projected to reach $16.1 billion by 2031, registering a CAGR of 9.9% from 2022 to 2031.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A11471
Market Drivers and Growth Opportunities:
- Theโฆ
Polysulfone Market Insights, Growth Trends and Forecast from 2026 to 2031
The rapid development of advanced polymer processing technologies such as extrusion, injection molding, and 3D printing has significantly simplified the manufacturing of high-performance polysulfone components. These advancements are expanding the adoption of polysulfone across a broader range of applications, from healthcare and electronics to automotive and aerospace industries.
According to a report published by Allied Market Research, titled "Polysulfone Market by Type, Grade, Application, End User Industry, and Region: Global Opportunityโฆ
Polyester Fiber Market Analysis, Growth Drivers and Forecast from 2026 to 2032
According to the study, the global polyester fiber market was valued at $81.1 billion in 2022 and is projected to reach $160.1 billion by 2032, registering a CAGR of 7.1% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A10583
Key Growth Drivers and Market Dynamics:
- The growth of the global polyester fiber market is primarily driven by surging demand from the textile and home furnishing industries, along with the rapidโฆ
Polyurethane Sealant Market Trends and Growth Outlook, Projections from 2026 to โฆ
The global polyurethane sealant market is witnessing steady growth, primarily driven by rising demand from the construction sector. The construction industry remains one of the largest consumers of polyurethane sealants, owing to their extensive use in bonding, sealing, and gap-filling applications. Rapid economic growth, increasing urbanization, and expanding residential, commercial, and infrastructure development projects across the globe are significantly boosting market demand.
The global polyurethane sealant market was valued at $3.0โฆ
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
โข F. Hoffmann-la Roche Ltd
โข Abbott
โข Oxford Nanopore Technologies
โข Thermo Fisher Scientific Inc.
โข Illumina, Inc.
โข QIAGEN
โข Agilent Technologies, Inc.
โข Myriad Genetics, Inc.
โข Admera Health
Contact Us:
If you have any queries aboutโฆ
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 toโฆ
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis ofโฆ
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with theirโฆ
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complexโฆ
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certainโฆ
